Quantcast

Latest Tykerb Stories

2010-03-03 13:18:10

A combination of two targeted therapies already shown to be effective in breast cancer packs an effective one-two punch against a subset of gastric cancers that have a specific genetic mutation

2010-01-29 18:46:00

PHILADELPHIA, Jan. 29 /PRNewswire/ -- GlaxoSmithKline (NYSE: GSK) announced today that the U.S.

2010-01-29 16:58:00

Provides oral regime for hormone positive and HER2-positive advanced breast cancer SILVER SPRING, Md., Jan. 29 /PRNewswire-USNewswire/ -- The U.S.

2009-12-11 12:30:00

LONDON and PHILADELPHIA, Dec. 11 /PRNewswire/ -- In a clinical study, women with an aggressive form of breast cancer experienced a median survival of 14 months when treated with an investigational combination of TYKERB® (lapatinib) plus HERCEPTIN® (trastuzumab).

d4892899a41d2ccabf5f89ad79f3e281
2009-04-02 09:20:00

GlaxoSmithKline PLC has petitioned the United States and Europe for permission in to market an already accessible breast-cancer drug as a first-line treatment option.

2009-04-01 08:00:00

LONDON and PHILADELPHIA, April 1, /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE: GSK) today announced the submission of two simultaneous regulatory applications to expand the use of TYVERB(R)/TYKERB(R) (lapatinib).

2006-06-03 14:18:49

By Lisa Richwine ATLANTA (Reuters) - An experimental drug added to chemotherapy slowed aggressive, late-stage breast cancers that resumed growing despite standard treatment with the drug Herceptin, U.S. researchers said on Saturday.


Word of the Day
megalophonous
  • Having a loud voice; vociferous; clamorous.
  • Of grand or imposing sound.
The word 'megalophonous' comes from Greek roots meaning 'big' and 'sound'.